Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
646
+2
+0.3% +$685 0.1% 101
2026
Q1
$227K Hold
644
0.12% 89
2025
Q4
$213K Buy
+644
New +$204K 0.11% 93
2025
Q2
Sell
-651
Closed -$203K 98
2025
Q1
$203K Buy
+651
New +$192K 0.15% 88

Other funds holding AMGN

Ring Mountain Capital's AMGN Position: Q2 2026 in Review

Ring Mountain Capital increased its Amgen (AMGN) stake by 0.31% in Q2 2026, buying an estimated $685 and bringing the position to 646 shares worth $234K. The position accounts for 0.1% of the portfolio, ranked #101.

Ring Mountain Capital first reported a position in AMGN in Q1 2025 and has held it in 4 quarters since. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ring Mountain Capital held 646 shares of Amgen worth $234K as of Q2 2026.
  • Ring Mountain Capital bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.1% of Ring Mountain Capital's portfolio in Q2 2026, its #101 holding.
  • Ring Mountain Capital first reported a position in Amgen in Q1 2025 and has held it in 4 quarters since.
  • 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ring Mountain Capital's 13F filing for Q2 2026, filed 11 Aug 2026.